What is the Glenmark Pharmaceuticals Ltd share price today?

The share price of NSE:GLENMARK-EQ on 07 Sep 2026 (as of 10:59:21 IST) is ₹2455.80.

What is the NSE:GLENMARK-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:GLENMARK-EQ 52 week high low range shows a high of ₹2537.60 and a low of ₹1792.60.

What is the Glenmark Pharmaceuticals Ltd market cap?

As on 07 Sep 2026, Glenmark Pharmaceuticals Ltd market cap is ₹68495.90 Cr.

What is the shareholding pattern of Glenmark Pharmaceuticals Ltd Stock?

The shareholding pattern of Glenmark Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 46.65% Foreign Institutional Investors (FII): 20.89% Domestic Institutional Investors (DII): 1.84% Mutual Funds: 16.76% Retail & Others: 13.86% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Glenmark Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Glenmark Pharmaceuticals Ltd is 38.10, and the Price-to-Book (PB) ratio is 5.75, as on 07 Sep 2026.

Glenmark Pharmaceuticals Share Price

2430.40-44.60 (-1.80%)

+20.51% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.80%

1 Week

-0.69%

1 Month

+1.27%

3 Month

+12.81%

6 Month

+11.97%

YTD

+19.42%

1 Year

+20.51%

5 Year

+374.69%

10 Year

+156.98%

Max

+7378.15%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2422.00

2306.30

2142.80

1966.50

1792.60

High

2470.00

2482.60

2537.60

About

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The Company Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

GLENMARKNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

2430.4-17 (-0.69%)

2422

2482.60

69,769Cr

Glenmark Pharmaceuticals Share Price

2430.40-44.60 (-1.80%)

+20.51% past 1 Year

Financial overview

Compounded Sales Growth

10 years8%

5 years9%

3 years14%

Last year27%

Compounded Profit Growth

10 years6%

5 years7%

3 years66%

Last year30%

Stock Price CAGR

10 years10%

5 years37%

3 years46%

1 year23%

Return on Equity

10 years11%

5 years3%

3 years2%

Last year14%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
8%	9%	14%	27%
6%	7%	66%	30%
10%	37%	46%	23%
11%	3%	2%	14%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

GLENMARK

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
2,430.4	₹69769 Cr	38.81	17.11	85.56	₹1362 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006	Mar 2005	Mar 2004	Mar 2003	Mar 2002
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹27 Cr	₹27 Cr	₹27 Cr	₹27 Cr	₹27 Cr	₹27 Cr	₹25 Cr	₹25 Cr	₹24 Cr	₹44 Cr	₹44 Cr	₹22 Cr	₹20 Cr	₹20 Cr
₹34 Cr	₹9 Cr	₹18 Cr	₹18 Cr	₹16 Cr	₹22 Cr	₹14 Cr	₹11 Cr	₹11 Cr	₹1 Cr	₹1 Cr	₹20,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹44,000	₹4 L	₹16 L	₹62 L	₹44 L
₹10450 Cr	₹8812 Cr	₹7801 Cr	₹9428 Cr	₹9042 Cr	₹7015 Cr	₹6029 Cr	₹5566 Cr	₹5125 Cr	₹4463 Cr	₹3600 Cr	₹1756 Cr	₹2956 Cr	₹2736 Cr	₹2375 Cr	₹2010 Cr	₹2328 Cr	₹1573 Cr	₹1493 Cr	₹662 Cr	₹349 Cr	₹285 Cr	₹212 Cr	₹132 Cr	₹109 Cr
₹10450 Cr	₹8812 Cr	₹7801 Cr	₹9428 Cr	₹9042 Cr	₹7015 Cr	₹6029 Cr	₹5566 Cr	₹5125 Cr	₹4463 Cr	₹3600 Cr	₹1756 Cr	₹2956 Cr	₹2736 Cr	₹2375 Cr	₹2010 Cr	₹2328 Cr	₹1573 Cr	₹1493 Cr	₹662 Cr	₹349 Cr	₹285 Cr	₹212 Cr	₹132 Cr	₹109 Cr
₹10512 Cr	₹8849 Cr	₹7848 Cr	₹9474 Cr	₹9087 Cr	₹7065 Cr	₹6071 Cr	₹5605 Cr	₹5163 Cr	₹4493 Cr	₹3630 Cr	₹1783 Cr	₹2983 Cr	₹2763 Cr	₹2402 Cr	₹2037 Cr	₹2355 Cr	₹1598 Cr	₹1518 Cr	₹686 Cr	₹393 Cr	₹329 Cr	₹234 Cr	₹153 Cr	₹130 Cr
-₹32 L	-₹37 L	-₹38 L	₹365 Cr	₹351 Cr	-₹35 L	-₹39 L	-₹38 L	-₹37 L	-₹42 L	-₹30 L	-₹19 L	₹13 Cr	₹24 Cr	₹25 Cr	₹27 Cr	₹13 Cr	₹3 Cr	₹1 Cr	₹0	₹0	₹0	₹44 L	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2429 Cr	₹1920 Cr	₹1312 Cr	₹617 Cr	₹241 Cr	₹383 Cr	₹196 Cr	₹175 Cr	₹147 Cr	₹129 Cr	₹103 Cr	₹119 Cr	₹82 Cr
₹0	₹513 Cr	₹0	₹3852 Cr	₹2572 Cr	₹3889 Cr	₹4043 Cr	₹3574 Cr	₹4142 Cr	₹4536 Cr	₹2487 Cr	₹2574 Cr	₹0	₹0	₹0	₹0	₹1628 Cr	₹1712 Cr	₹795 Cr	₹762 Cr	₹588 Cr	₹308 Cr	₹12 Cr	₹5 Cr	₹10 Cr
-₹1245 Cr	-₹1066 Cr	-₹1049 Cr	-₹1805 Cr	-₹1655 Cr	-₹1506 Cr	-₹1439 Cr	-₹1383 Cr	-₹1320 Cr	-₹1311 Cr	-₹1065 Cr	₹53 Cr	-₹514 Cr	-₹380 Cr	-₹267 Cr	-₹108 Cr	₹71 Cr	₹57 Cr	₹95 Cr	₹72 Cr	₹42 Cr	₹31 Cr	₹27 Cr	₹25 Cr	₹20 Cr
₹2842 Cr	₹662 Cr	₹692 Cr	₹575 Cr	₹352 Cr	₹421 Cr	₹429 Cr	₹89 Cr	₹3 Cr	₹33 Cr	₹77 Cr	₹122 Cr	₹52 Cr	₹85 Cr	₹78 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹177 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹15 Cr	₹7 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1773 Cr	₹109 Cr	-₹357 Cr	₹2621 Cr	₹1270 Cr	₹2804 Cr	₹3033 Cr	₹2280 Cr	₹2824 Cr	₹3258 Cr	₹1499 Cr	₹2749 Cr	₹1967 Cr	₹1625 Cr	₹1138 Cr	₹519 Cr	₹1940 Cr	₹2151 Cr	₹1085 Cr	₹1009 Cr	₹777 Cr	₹468 Cr	₹141 Cr	₹150 Cr	₹113 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3744 Cr	₹3051 Cr	₹2536 Cr	₹2000 Cr	₹2289 Cr	₹2238 Cr	₹2126 Cr	₹2221 Cr	₹1870 Cr	₹1743 Cr	₹1941 Cr	₹1948 Cr	₹1363 Cr	₹1037 Cr	₹789 Cr	₹657 Cr	₹379 Cr	₹343 Cr	₹231 Cr	₹160 Cr	₹108 Cr	₹75 Cr	₹49 Cr	₹39 Cr	₹37 Cr
₹1468 Cr	₹436 Cr	₹1517 Cr	₹1605 Cr	₹1446 Cr	₹886 Cr	₹1002 Cr	₹1013 Cr	₹691 Cr	₹509 Cr	₹1137 Cr	₹1264 Cr	₹973 Cr	₹763 Cr	₹415 Cr	₹110 Cr	₹119 Cr	₹96 Cr	₹72 Cr	₹72 Cr	₹64 Cr	₹37 Cr	₹24 Cr	₹22 Cr	₹11 Cr
₹0	₹1681 Cr	₹833 Cr	₹350 Cr	₹370 Cr	₹513 Cr	₹443 Cr	₹303 Cr	₹295 Cr	₹187 Cr	₹787 Cr	₹348 Cr	₹353 Cr	₹368 Cr	₹687 Cr	₹1480 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1165 Cr	₹798 Cr	₹932 Cr	₹591 Cr	₹585 Cr	₹564 Cr	₹556 Cr	₹484 Cr	₹432 Cr	₹263 Cr	₹134 Cr	₹217 Cr	₹260 Cr	₹33 Cr	₹11 Cr	₹12 Cr	₹20 Cr	₹16 Cr	₹18 Cr	₹7 Cr	₹81 L	₹24 L	₹4 Cr	₹1 Cr	₹7 Cr
₹6376 Cr	₹5967 Cr	₹5819 Cr	₹4546 Cr	₹4689 Cr	₹4201 Cr	₹4126 Cr	₹4021 Cr	₹3288 Cr	₹2703 Cr	₹3999 Cr	₹3777 Cr	₹2949 Cr	₹2201 Cr	₹1902 Cr	₹2259 Cr	₹519 Cr	₹456 Cr	₹321 Cr	₹240 Cr	₹173 Cr	₹112 Cr	₹77 Cr	₹62 Cr	₹55 Cr
₹18661 Cr	₹14925 Cr	₹13309 Cr	₹17566 Cr	₹15397 Cr	₹14069 Cr	₹13229 Cr	₹11906 Cr	₹11275 Cr	₹10453 Cr	₹9128 Cr	₹8309 Cr	₹7912 Cr	₹6614 Cr	₹5466 Cr	₹4842 Cr	₹4827 Cr	₹4209 Cr	₹2926 Cr	₹1935 Cr	₹1343 Cr	₹910 Cr	₹453 Cr	₹365 Cr	₹297 Cr
₹788 Cr	₹800 Cr	₹1063 Cr	₹337 Cr	₹361 Cr	₹384 Cr	₹271 Cr	₹74 Cr	₹47 Cr	₹37 Cr	₹37 Cr	₹129 Cr	₹129 Cr	₹118 Cr	₹131 Cr	₹191 Cr	₹616 Cr	₹499 Cr	₹233 Cr	₹161 Cr	₹26 Cr	₹24 Cr	₹25 Cr	₹23 Cr	₹36 Cr
₹0	₹2194 Cr	₹991 Cr	₹4348 Cr	₹3670 Cr	₹4687 Cr	₹4869 Cr	₹4449 Cr	₹4639 Cr	₹4724 Cr	₹3988 Cr	₹3800 Cr	₹3267 Cr	₹2765 Cr	₹2245 Cr	₹2108 Cr	₹1869 Cr	₹2094 Cr	₹991 Cr	₹937 Cr	₹735 Cr	₹437 Cr	₹115 Cr	₹125 Cr	₹92 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹12072 Cr	₹10365 Cr	₹9620 Cr	₹10360 Cr	₹10214 Cr	₹8732 Cr	₹8270 Cr	₹6527 Cr	₹5368 Cr	₹4770 Cr	₹4301 Cr	₹3495 Cr	₹3633 Cr	₹2935 Cr	₹2651 Cr	₹2383 Cr	₹2176 Cr	₹1839 Cr	₹1124 Cr	₹709 Cr	₹530 Cr	₹389 Cr	₹184 Cr	₹125 Cr	₹143 Cr
₹6157 Cr	₹5878 Cr	₹5409 Cr	₹4938 Cr	₹4326 Cr	₹3603 Cr	₹3241 Cr	₹2857 Cr	₹2338 Cr	₹2015 Cr	₹1707 Cr	₹1480 Cr	₹743 Cr	₹529 Cr	₹414 Cr	₹317 Cr	₹388 Cr	₹272 Cr	₹206 Cr	₹117 Cr	₹77 Cr	₹52 Cr	₹35 Cr	₹24 Cr	₹18 Cr
₹5915 Cr	₹4487 Cr	₹4210 Cr	₹5422 Cr	₹5887 Cr	₹5129 Cr	₹5029 Cr	₹3670 Cr	₹3030 Cr	₹2755 Cr	₹2594 Cr	₹2015 Cr	₹2890 Cr	₹2406 Cr	₹2237 Cr	₹2067 Cr	₹1787 Cr	₹1566 Cr	₹919 Cr	₹593 Cr	₹453 Cr	₹337 Cr	₹149 Cr	₹100 Cr	₹125 Cr
₹428 Cr	₹542 Cr	₹419 Cr	₹1066 Cr	₹921 Cr	₹1218 Cr	₹1091 Cr	₹1234 Cr	₹993 Cr	₹630 Cr	₹498 Cr	₹444 Cr	₹201 Cr	₹416 Cr	₹248 Cr	₹146 Cr	₹601 Cr	₹545 Cr	₹337 Cr	₹218 Cr	₹127 Cr	₹13 Cr	₹25 Cr	₹23 Cr	₹7 Cr
₹42 Cr	₹56 Cr	₹790 Cr	₹45 Cr	₹50 Cr	₹25 Cr	₹25 Cr	₹30 Cr	₹15 Cr	₹16 Cr	₹17 Cr	₹17 Cr	₹0	₹0	₹0	₹0	₹18 Cr	₹18 Cr	₹19 Cr	₹19 Cr	₹20 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹1 Cr
₹42 Cr	₹56 Cr	₹790 Cr	₹45 Cr	₹50 Cr	₹25 Cr	₹25 Cr	₹30 Cr	₹15 Cr	₹16 Cr	₹17 Cr	₹17 Cr	₹0	₹0	₹0	₹0	₹18 Cr	₹18 Cr	₹19 Cr	₹19 Cr	₹20 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹1 Cr
₹493 Cr	₹243 Cr	₹212 Cr	₹181 Cr	₹161 Cr	₹146 Cr	₹124 Cr	₹94 Cr	₹120 Cr	₹99 Cr	₹70 Cr	₹468 Cr	₹33 Cr	₹37 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹3 Cr	₹9 Cr	₹7 Cr	₹3 Cr	₹7 Cr	₹28 Cr	₹26 Cr	₹16 Cr	₹56 L	₹13 L	₹16 L	₹27 L	₹20 Cr	₹22 Cr	₹33 Cr	₹31 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹7362 Cr	₹5630 Cr	₹5881 Cr	₹6840 Cr	₹7115 Cr	₹6709 Cr	₹6425 Cr	₹5209 Cr	₹4286 Cr	₹3578 Cr	₹3224 Cr	₹2978 Cr	₹3150 Cr	₹2887 Cr	₹2519 Cr	₹2243 Cr	₹2406 Cr	₹2130 Cr	₹1275 Cr	₹829 Cr	₹600 Cr	₹365 Cr	₹189 Cr	₹138 Cr	₹133 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3431 Cr	₹3029 Cr	₹2513 Cr	₹2374 Cr	₹2500 Cr	₹2277 Cr	₹2136 Cr	₹2252 Cr	₹2031 Cr	₹2139 Cr	₹1568 Cr	₹1269 Cr	₹933 Cr	₹844 Cr	₹788 Cr	₹807 Cr	₹708 Cr	₹630 Cr	₹401 Cr	₹270 Cr	₹158 Cr	₹119 Cr	₹82 Cr	₹44 Cr	₹48 Cr
₹4963 Cr	₹3342 Cr	₹1858 Cr	₹3665 Cr	₹3101 Cr	₹2572 Cr	₹2409 Cr	₹2195 Cr	₹2332 Cr	₹2404 Cr	₹2493 Cr	₹2512 Cr	₹2156 Cr	₹1640 Cr	₹1244 Cr	₹1131 Cr	₹1078 Cr	₹955 Cr	₹807 Cr	₹566 Cr	₹382 Cr	₹238 Cr	₹130 Cr	₹123 Cr	₹83 Cr
₹1176 Cr	₹1705 Cr	₹1659 Cr	₹1160 Cr	₹1412 Cr	₹1139 Cr	₹1111 Cr	₹938 Cr	₹1235 Cr	₹1058 Cr	₹857 Cr	₹776 Cr	₹801 Cr	₹607 Cr	₹322 Cr	₹196 Cr	₹107 Cr	₹71 Cr	₹157 Cr	₹106 Cr	₹106 Cr	₹127 Cr	₹8 Cr	₹5 Cr	₹10 Cr
₹308 Cr	₹145 Cr	₹178 Cr	₹317 Cr	₹297 Cr	₹325 Cr	₹237 Cr	₹320 Cr	₹466 Cr	₹374 Cr	₹156 Cr	₹31 Cr	₹13 Cr	₹13 Cr	₹9 Cr	₹61 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1421 Cr	₹1075 Cr	₹1219 Cr	₹908 Cr	₹972 Cr	₹1047 Cr	₹911 Cr	₹993 Cr	₹925 Cr	₹900 Cr	₹831 Cr	₹743 Cr	₹860 Cr	₹623 Cr	₹585 Cr	₹405 Cr	₹527 Cr	₹422 Cr	₹287 Cr	₹164 Cr	₹97 Cr	₹58 Cr	₹40 Cr	₹51 Cr	₹16 Cr
₹11300 Cr	₹9295 Cr	₹7428 Cr	₹8424 Cr	₹8282 Cr	₹7360 Cr	₹6804 Cr	₹6697 Cr	₹6989 Cr	₹6875 Cr	₹5904 Cr	₹5331 Cr	₹4763 Cr	₹3727 Cr	₹2947 Cr	₹2599 Cr	₹2421 Cr	₹2079 Cr	₹1651 Cr	₹1105 Cr	₹741 Cr	₹542 Cr	₹261 Cr	₹224 Cr	₹157 Cr
₹4923 Cr	₹3328 Cr	₹1610 Cr	₹3877 Cr	₹3593 Cr	₹3159 Cr	₹2678 Cr	₹2676 Cr	₹3701 Cr	₹4172 Cr	₹1905 Cr	₹1554 Cr	₹1814 Cr	₹1525 Cr	₹1045 Cr	₹340 Cr	₹1902 Cr	₹1623 Cr	₹1330 Cr	₹866 Cr	₹569 Cr	₹430 Cr	₹184 Cr	₹162 Cr	₹103 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹7 Cr
₹18661 Cr	₹14925 Cr	₹13309 Cr	₹17566 Cr	₹15397 Cr	₹14069 Cr	₹13229 Cr	₹11906 Cr	₹11275 Cr	₹10453 Cr	₹9128 Cr	₹8309 Cr	₹7912 Cr	₹6614 Cr	₹5466 Cr	₹4842 Cr	₹4827 Cr	₹4209 Cr	₹2926 Cr	₹1935 Cr	₹1343 Cr	₹910 Cr	₹453 Cr	₹365 Cr	₹297 Cr
₹371	₹313	₹277	₹335	₹321	₹250	₹215	₹198	₹183	₹159	₹129	₹66	₹110	₹102	₹89	₹75	₹87	₹64	₹61	₹57	₹31	₹26	₹37	₹27	₹111
₹371	₹313	₹277	₹335	₹321	₹250	₹215	₹198	₹183	₹159	₹129	₹66	₹110	₹102	₹89	₹75	₹87	₹64	₹61	₹29	₹16	₹13	₹9	₹1	₹6

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006	Mar 2005
₹1985 Cr	₹1399 Cr	₹569 Cr	₹868 Cr	₹1441 Cr	₹1382 Cr	₹1096 Cr	₹1301 Cr	₹1119 Cr	₹1491 Cr	₹1044 Cr	₹544 Cr	₹697 Cr	₹739 Cr	₹488 Cr	₹482 Cr	₹384 Cr	₹269 Cr	₹711 Cr	₹361 Cr	₹112 Cr	₹127 Cr
₹2690 Cr	₹947 Cr	₹1010 Cr	₹1472 Cr	₹787 Cr	₹645 Cr	₹636 Cr	₹330 Cr	₹571 Cr	₹727 Cr	₹391 Cr	₹523 Cr	₹710 Cr	₹342 Cr	₹484 Cr	₹190 Cr	₹265 Cr	₹274 Cr	₹133 Cr	₹86 Cr	₹44 Cr	₹36 Cr
-₹447 Cr	-₹2494 Cr	-₹797 Cr	-₹1074 Cr	-₹561 Cr	-₹386 Cr	₹127 Cr	₹136 Cr	₹309 Cr	-₹862 Cr	-₹612 Cr	-₹267 Cr	-₹290 Cr	-₹268 Cr	-₹35 Cr	₹353 Cr	-₹209 Cr	-₹388 Cr	-₹385 Cr	-₹326 Cr	-₹166 Cr	-₹128 Cr
₹4228 Cr	-₹147 Cr	₹782 Cr	₹1266 Cr	₹1667 Cr	₹1641 Cr	₹1859 Cr	₹1767 Cr	₹2000 Cr	₹1356 Cr	₹823 Cr	₹799 Cr	₹1117 Cr	₹813 Cr	₹937 Cr	₹1024 Cr	₹440 Cr	₹155 Cr	₹460 Cr	₹121 Cr	-₹10 Cr	₹36 Cr
₹3445 Cr	-₹828 Cr	-₹265 Cr	₹625 Cr	₹1109 Cr	₹1131 Cr	₹1392 Cr	₹1324 Cr	₹1648 Cr	₹657 Cr	₹345 Cr	₹482 Cr	₹854 Cr	₹648 Cr	₹804 Cr	₹931 Cr	₹352 Cr	₹16 Cr	₹372 Cr	₹93 Cr	-₹27 Cr	₹14 Cr
-₹1283 Cr	₹2 Cr	₹4561 Cr	-₹528 Cr	-₹333 Cr	-₹675 Cr	-₹784 Cr	-₹699 Cr	-₹1013 Cr	-₹712 Cr	-₹880 Cr	-₹540 Cr	-₹368 Cr	-₹464 Cr	-₹278 Cr	-₹367 Cr	-₹387 Cr	-₹950 Cr	-₹510 Cr	-₹269 Cr	-₹257 Cr	-₹191 Cr
-₹2709 Cr	₹787 Cr	-₹3906 Cr	-₹77 Cr	-₹520 Cr	-₹442 Cr	-₹445 Cr	-₹739 Cr	-₹468 Cr	₹543 Cr	₹699 Cr	₹199 Cr	-₹98 Cr	₹195 Cr	-₹361 Cr	-₹436 Cr	₹70 Cr	₹849 Cr	₹189 Cr	₹176 Cr	₹262 Cr	₹297 Cr
-₹547 Cr	-₹38 Cr	₹389 Cr	₹19 Cr	₹255 Cr	₹14 Cr	₹164 Cr	-₹114 Cr	₹166 Cr	₹488 Cr	₹163 Cr	₹141 Cr	₹388 Cr	₹379 Cr	₹165 Cr	₹128 Cr	₹36 Cr	-₹85 Cr	₹51 Cr	₹16 L	-₹22 Cr	₹120 Cr
₹1676 Cr	₹1658 Cr	₹1443 Cr	₹1411 Cr	₹1138 Cr	₹1110 Cr	₹936 Cr	₹1233 Cr	₹1056 Cr	₹857 Cr	₹764 Cr	₹795 Cr	₹605 Cr	₹320 Cr	₹195 Cr	₹104 Cr	₹71 Cr	₹157 Cr	₹106 Cr	₹106 Cr	₹127 Cr	₹7 Cr
₹0	₹0	₹0	₹67 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	-₹192 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹46 Cr	₹56 Cr	₹18 Cr	₹12 Cr	₹18 Cr	₹14 Cr	₹10 Cr	-₹184 Cr	₹11 Cr	-₹289 Cr	-₹70 Cr	-₹172 Cr	-₹198 Cr	-₹94 Cr	-₹40 Cr	-₹36 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹1175 Cr	₹1676 Cr	₹1658 Cr	₹1443 Cr	₹1411 Cr	₹1138 Cr	₹1110 Cr	₹936 Cr	₹1233 Cr	₹1056 Cr	₹857 Cr	₹764 Cr	₹795 Cr	₹605 Cr	₹320 Cr	₹195 Cr	₹107 Cr	₹71 Cr	₹157 Cr	₹106 Cr	₹106 Cr	₹127 Cr

Fundamental Ratios

Consolidated

Standalone

Glenmark Pharmaceuticals Share Price

2430.40-44.60 (-1.80%)

+20.51% past 1 Year

Shareholding summary

Promoters

46.65%

FII

20.89%

DII

1.84%

16.76%

Others

13.86%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
46.65%	46.65%	46.65%	46.65%	46.65%	46.65%
20.89%	20.35%	19.20%	20.73%	20.62%	23.15%
1.84%	2.48%	2.23%	2.30%	2.09%	1.74%
16.76%	16.80%	17.86%	16.31%	15.55%	12.86%
13.86%	13.72%	14.06%	14.01%	15.09%	15.60%

Bulk & block deals

Name

Graviton Research Capital Llp

Integrated Core Strategies (Asia) Pte. Ltd.

Ubs Ag

Ubs Principal Capital Asia Limited

Ishares Core Msci Emerging Markets Etf

Ishares Msci India Small-Cap Etf

Ishares Core Emerging Markets Mauritius Co

Ishares India Sc Mauritius Company

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
11 Jul 2025	Purchase	328.05 Cr	₹2,171.67	15.11 L	Bulk	0.535244	NSE
11 Jul 2025	Sell	328.30 Cr	₹2,173.31	15.11 L	Bulk	0.535244	NSE
25 Mar 2025	Purchase	39.48 Cr	₹1,492.65	2.64 L	Block	0.093707	NSE
25 Mar 2025	Sell	39.48 Cr	₹1,492.65	2.64 L	Block	0.093707	NSE
23 Jan 2025	Purchase	101.38 Cr	₹1,510	6.71 L	Block	0.237893	NSE
23 Jan 2025	Sell	101.38 Cr	₹1,510	6.71 L	Block	0.237893	NSE
25 Oct 2022	Purchase	12.04 Cr	₹397.90	3.03 L	Block	0.107227	BSE
25 Oct 2022	Purchase	1.56 Cr	₹397.90	39.27 K	Block	0.013913	BSE
25 Oct 2022	Sell	12.04 Cr	₹397.90	3.03 L	Block	0.107227	BSE
25 Oct 2022	Sell	1.56 Cr	₹397.90	39.27 K	Block	0.013913	BSE

Insider trading & SAST

Client name

Hdfc Mutual Fund

Mr. Praveen D Kurkal

Hsbc Global Asset Management (Hong Kong) Ltd

Robin Pinto

Sridhar Gorthi

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
08 Jul 2025	Other	Acquisition	0.13	5.07	0	—	3.57 L	17 Jun 2025	Market	1,43,05,181	SAST	29(1)	—
25 Sep 2023	Designated Person	Disposal	0.000177	0	4.26 L	₹851.02	500	20 Sep 2023	Market Sale	2,590	Insider Trading	—	Equity Shares
25 Sep 2023	Designated Person	Disposal	0.000354	0	8.52 L	₹852	1 K	20 Sep 2023	Market Sale	590	Insider Trading	—	Equity Shares
25 Sep 2023	Designated Person	Disposal	0.000354	0	8.52 L	₹852	1 K	20 Sep 2023	Market Sale	1,590	Insider Trading	—	Equity Shares
25 Sep 2023	Designated Person	Disposal	0.000177	0	4.26 L	₹851.02	500	20 Sep 2023	Market Sale	2,590	Insider Trading	—	Equity Shares
25 Sep 2023	Designated Person	Disposal	0.000354	0	8.52 L	₹852	1 K	20 Sep 2023	Market Sale	590	Insider Trading	—	Equity Shares
25 Sep 2023	Designated Person	Disposal	0.000354	0	8.52 L	₹852	1 K	20 Sep 2023	Market Sale	1,590	Insider Trading	—	Equity Shares
12 Apr 2023	—	Disposal	0.07	3.04	0	—	2.16 L	06 Apr 2023	Market	85,97,867	SAST	29(2)	—
24 Nov 2021	Promoter Group	Acquisition	0.000089	0.18	1.23 L	₹490.19	250	23 Nov 2021	Market Purchase	4,97,500	Insider Trading	—	Equity Shares
17 Nov 2021	Director	Disposal	0.000198	0	2.99 L	₹535.68	559	15 Nov 2021	Market Sale	0	Insider Trading	—	Equity Shares

Glenmark Pharmaceuticals Share Price

2430.40-44.60 (-1.80%)

+20.51% past 1 Year

Corporate Actions

Date

Type

Details

2026-08-31

Dividend

2.5

2025-10-03

Dividend

2.5

2025-09-15

Dividend

2.5

2024-09-13

Dividend

2.5

2023-09-18

Dividend

2.5

2022-09-12

Dividend

2.5

2021-09-08

Dividend

2.5

2020-09-17

Dividend

2.5

2019-09-19

Dividend

2.0

2018-09-19

Dividend

2.0

2017-09-20

Dividend

2.0

2016-08-03

Dividend

2.0

2015-09-10

Dividend

2.0

2014-07-10

Dividend

2.0

2013-07-18

Dividend

2.0

2012-07-19

Dividend

2.0

2011-07-28

Dividend

0.4

2010-09-16

Dividend

0.4

Company details

Registered office

B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road Mumbai Maharashtra PIN: 400026 Tel No: 022 40189999 Fax No: 022 40189988 Email: [email protected] Internet: www.glenmarkpharma.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Rashmi Khandelwal, Company Secretary & Compliance Officer

Glenn Saldanha, Chairman & Managing Director

Anurag Mantri, Whole Time Director & Global Chief Financial Officer

Cherylann Pinto, Whole Time Director & Corporate Services

B E Saldanha, Promoter & Non-Executive Director

Saira Ramasastry, Non Executive Independent Director

Vijayalakshmi Iyer, Non Executive Independent Director

Dipankar Bhattacharjee, Non Executive Independent Director

Patricia Andrews, Non Executive Independent Director

Pradeep Kumar Sinha, Non Executive Independent Director

Details

Glenmark Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals Share Price

Oscillators

Moving averages

Glenmark Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Glenmark Pharmaceuticals Share Price

Corporate Actions

Company details

Glenmark Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Glenmark Pharmaceuticals Share Price

News

Glenmark Reports Rs 37.28 Crores NSE Block Trade At Rs 2473

Glenmark Pharma Receives US FDA EIR With VAI Status For Goa Facility

Glenmark Pharma unit launches US generic calcium gluconate injectable

Glenmark Pharma gets US FDA nod for fluticasone nasal spray sales

Glenmark highlights significant revenue dependence on US market for sales mix

Glenmark sets FY27 margin guidance band, targets 21-22 percent range

Glenmark estimates quarterly US sales above Rs 10.00 crores threshold

Glenmark sees strong upside in US sales trajectory, boosting growth outlook

Glenmark Pharma targets double-digit India growth and debt-free balance sheet

Glenmark Pharma guides for steady operating margins despite cost pressures

Glenmark Pharma targets stronger Europe growth with sustained R&D investments

Glenmark Pharma flags over 18 percent annual growth led by North America recovery

Glenmark Pharma reports strong Q1 EBITDA growth and margin expansion YoY

Glenmark Pharma reports strong Q1 revenue growth on year-over-year basis

Glenmark Pharma Q1 consolidated net profit surges sharply year-on-year

Glenmark Pharma Q1 consolidated PBT rises sharply on strong YoY growth

Glenmark Pharma unit launches generic Sugammadex injection in US market

Glenmark Pharma outlines major shift toward innovation-led revenue mix over medium term

Glenmark Pharmaceuticals schedules Q1 FY27 earnings call on August 3, 2026

Glenmark Pharma gains US FDA nod to extend Ryaltris paediatric use

Glenmark Pharmaceuticals Ltd Share Price Today

Glenmark Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator